Mizuho Securities analyst Ann Hynes reiterated a Hold rating on McKesson (NYSE: MCK) on August 10 and set a price target of $133. The company’s shares closed on Friday at $123.14, close to its 52-week low of $122.63.
According to TipRanks.com, Hynes is a 3-star analyst with an average return of 3.9% and a 55.9% success rate. Hynes covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Encompass Health Corporation, and Walgreens Boots Alliance.
McKesson has an analyst consensus of Moderate Buy, with a price target consensus of $150.43, which is a 22.2% upside from current levels. In a report issued on July 26, Robert W. Baird also reiterated a Hold rating on the stock with a $134 price target.
.
See today’s analyst top recommended stocks >>
Based on McKesson’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $52.61 billion and GAAP net loss of $138 million. In comparison, last year the company earned revenue of $51.05 billion and had a net profit of $307 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions business segments.
